期刊文献+

支气管哮喘患者血浆中IL-33及可溶性ST2的水平和临床意义 被引量:1

Changes of plasma interleukin 33 and its soluble receptor ST-2 in asthmatic patients and its clinical significance
原文传递
导出
摘要 目的通过检测支气管哮喘(简称哮喘)患者血浆中自介素33(IL-33)和可溶性ST-2(sST-2)的表达水平,探讨哮喘患者血浆中IL-33和sST-2的作用和临床意义。方法①用ELISA法检测60例哮喘急性发作期患者和20例健康体检者外周血中IL-33和sST-2的血浆浓度。②对所有哮喘患者行肺功能检测(PTF)。③依据FEV1将哮喘患者分为3组:FEV1≥80%或PEF≥80%为轻度哮喘组,60%≤FEV1〈80%或60%≤PEF〈80%中度哮喘组,FEV1〈60%或PEF〈60%为重度哮喘组。结果①轻、中、重度哮喘急性发作期患者血浆中IL-33的水平较正常对照组升高(F=454.81,P=0.00),差异有统计学意义(P〈0.05)。②轻、中、重度哮喘急性发作期患者血浆中sST-2水平较正常对照组升高(F=96.71,P=0.00),差异有统计学意义(P〈O.05)。③哮喘急性发作期患者血浆中IL-33水平与FEV1%pred和PEF均呈明显负相关(P〈0.05)。结论IL-33和sST-2均参与了哮喘的发病过程,其血浆水平的变化可做为病情监测的一项血清学指标,且IL-33可作为重症哮喘和肺功能严重受损的一个标识。 Objective To study the changes of plasma interleukin-33 (IL-33) and its soluble receptor ST-2 (sST-2) in asthmatic patients,and investigate the clinical significance and the effect of IL-33 and sST-2 signal pathway in bronchial asthma (asthma). Methods The plasma levels of IL-33 and its sST-2 were detected by ELISA method in 60 patients with asthma,who were divided into the acute attack group,and 20 healthy controls. Of all patients with asthma pulmonary function test (PTF). ③ According to the pulmonary function (FEV1%pred) in patients with asthma were divided into 3 groups: FEV1≥ 80% and PEF≥80% for mild asthma group, 60≤FEV1〈80%, 60% 〈GPEF〈80% moderate asthma group,FEV1〈60% or PEF〈60% for patients with asthma. Results ①The plasma level of IL-33 with acute exacerbation of asthma in the mild group and moderate group and severe group was markedly increased compared with normal control group ( F = 454.81, P = 0.00), the differences were statistically significant ( P〈0.05). ②The plasma level of sST-2 in acute asthma with acute exacerbation of asthma in the mild group and moderate group and severe group was markedly increased compared with normal control group ( F = 96.71, P = 0.00), the differences were statistically significant ( P 〈0.05). ③The level of IL-33 were negatively correlated with FEV1% pred and PEF of acute exacerbation of asthma ( P 〈0.05). Conclusions IL-33 and its receptor sST-2 were involved in the pathogenesis of asthma,changes to the plasma levels of a serological index for monitoring disease progression,and IL-33 can be used as a sign of severe asthma and lung function is damaged badly.
出处 《国际呼吸杂志》 2015年第11期801-804,共4页 International Journal of Respiration
关键词 白介素-33 可溶性ST-2 支气管哮喘 Interleukin-33 sST-2 Bronchial asthma
  • 相关文献

参考文献11

  • 1Schmitz J, Owyang A, Oldham E, et al. IL33, an interleukin- l-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-assoclated cytokines :J]. Immunity,2005,23(5) :479-490.
  • 2Pr6fontaine D, Nadigel J, Chouiali F, et al. Increased IL-33 expression by epithelial cells in bronchial asthma I J]. J Allergy Clin lmmunol, 2010,125 (3) : 752-754.
  • 3支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185. 被引量:2518
  • 4Kurowska-Stolarska M, Hueber A, Stolarski B, et al. Interleukin 33:a novel mediator with a role in distinct diseasepathologies[J].J Intern Med,2011,269(1):29-35.
  • 5向志光,张连峰.IL-33及其受体ST2的研究进展[J].中国比较医学杂志,2009,19(9):59-62. 被引量:10
  • 6麻晓燕,罗雅玲,赖文岩,邵金莲,蓝海兵,梁振宇.支气管哮喘患者外周血、痰液中IL-33的含量及其相关性分析[J].第三军医大学学报,2011,33(14):1526-1529. 被引量:17
  • 7Hayakawa H, Hayakawa M, Kume A, et al. Soluble ST2 blocks interIeukin-33 signaling in allergic airway inflammation [J]. J Biol Chem,2007,282(36) :26369-26380.
  • 8Bianchetti L, Marini MA, Isgr6 M, et al. IL-33 promotes the migration and proliferation of circulating fibroeytes from patients with allergen-exacerbated asthma [J]. Biochem Biophys Res Commun,2012,426(1) :116-121.
  • 9Mizutani N, Nabe T, Yoshino S. lnterleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice[J]. Immunology, 2013,139(2) : 205-218.
  • 10Gordon ED,Solon M,Woodruf[ P, et aL Dysregulation of IL- 33 and ST2 instable asthma and acute asthma exacerbations FJ]. Am J Respir erit care Med, 2011,183 : A4269. ? ?.

二级参考文献26

  • 1Tominaga S. A putative protein of a growth specific eDNA from BALB/c-3T3 ceils is highly similar to the extracellular portion of mouse interleukin 1 receptor[ J]. FEBS Lett, 1989,258 : 301-304.
  • 2Ritual B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in silicosis:current understanding[J]. Curr Opin Pulm Med,2005,11 (2) : 169- 173.
  • 3Tominaga S, Yokota T, Yanagisawa K, et al. Nucleotide sequence of a complementary DNA for human ST2 [ J ]. Biochim Biophys Acta, 1992,1171:215 - 218.
  • 4Kumar S, Tzinms MN, Griswold DE, et al. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimulation[ J J. Biochem Biophys Res Commun, 1997, 235 : 474 - 478.
  • 5Tago K, Noda T, Hayakawa M, et al. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V [ J ]. Biochem Biophys Res Commun, 2001 285 : 1377 - 1383.
  • 6Baekkevold ES, Roussigne M, Ymnanaka T, et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules [ J 1. Am J Path, 2003,163 : 69 - 79.
  • 7Schmitz J,Owyang A, Oldham E, et al. IL-33, an interleukin-l-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]. Immunity,2005,23:479 - 490.
  • 8Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mueosal sites[ J]. Immunol Rev, 2008,226 : 172 - 190.
  • 9Suzukawa M,Iikura M,Koketsu R,et al. An IL-1 cytokine member, IL-33,induces human basophil activation via its ST2 receptor[J]. J Immunol,2008,181(9) :5981 - 5989.
  • 10Verri WA, Guerrero A, Fukada S, et al. IL-33 mediates antigeninduced cutaneous and articular hypernociception in mice [ J ]. Proc Nat Acad Sci, 2008,105 : 2723 - 2728.

共引文献2542

同被引文献37

  • 1Baekkevold ES, Roussign6 M, Yamanaka T, et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules [J]. Am J Pathol, 2003,163 ( 1 ) : 69-79.
  • 2Schmitz J, Owyang A, Ofdham E, et al. IL-33, an interleukin- l-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines [J]. Immunity, 2005, 23 (5): 479-490.
  • 3Liew FY, Pitman NI, McInnes lB. Disease-associated functions of IL-33 :the new kid in the IL-1 family[J]. Nat Rev Immunol, 2010,10(2) : 103-110.
  • 4Moussion C, Ortega N, Girard JP. The IL-l-like cytokine IL- 33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? [J]. PLoS One, 2008, 3 (10): e3331.
  • 5Hayakawa H, Hayakawa M, Kume A, et al. Soluble ST2 Blocks interleukin-33 signalin~ in allergic airway inflammation[J]. J Biol Chem, 2007, 282 (36) : 26369-26380.
  • 6Lee HY, Rhee CK, Kang JY, et al. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma[J]. Exp Lung Res, 2014, 40 (2): 66-76.
  • 7Cayrol C, Girard JP. IL-33 : an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy ~-J]. Curr Opin Immunol, 2014, 31: 31-37.
  • 8Garlanda C, Dinarello CA, Mantovani A. The Interleukin-1 Family: Back to the Future[J]. Immunity, 2013,39(6) : 1003- 1018.
  • 9Chang YJ, Kim HY, Albacker LA, et al. Innate lymphoid ceils mediate influenza-induced airway hyper-reactivity independently of adaptive immunity [J]. Nat Immunol, 2011,12(7) :631-638.
  • 10Doherty TA, Bruide DH. Group 2 innate lymphoid cells: new players in human allergic diseases[J'l. J Investig Allergol Clin Immunol, 2015,25(1) : 1-11.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部